Related references
Note: Only part of the references are listed.CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy
Ryuma Tokunaga et al.
CANCER TREATMENT REVIEWS (2018)
Serum sialylation changes in cancer
Zejian Zhang et al.
GLYCOCONJUGATE JOURNAL (2018)
Inflammatory breast cancer: a proposed conceptual shift in the UICC-AJCC TNM staging system
Tamer M. Fouad et al.
LANCET ONCOLOGY (2017)
A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma
Geny Piro et al.
ONCOIMMUNOLOGY (2017)
CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer
Holger Bronger et al.
BRITISH JOURNAL OF CANCER (2016)
Higher circulating levels of chemokine CXCL10 in patients with breast cancer: Evaluation of the influences of tumor stage and chemokine gene polymorphism
A. Jafarzadeh et al.
CANCER BIOMARKERS (2016)
Sandwich ELISA Using a Mouse/Human Chimeric CSLEX-1 Antibody
J. Yamashita et al.
CLINICAL CHEMISTRY (2016)
Dysregulated expression of Glycolipids in Tumor Cells: From negative Modulator of Anti-tumor immunity to Promising Targets for Developing Therapeutic Agents
Jose Luis Daniotti et al.
FRONTIERS IN ONCOLOGY (2016)
Protective Role of the Inflammatory CCR2/CCL2 Chemokine Pathway through Recruitment of Type 1 Cytotoxic γδ T Lymphocytes to Tumor Beds
Telma Lanca et al.
JOURNAL OF IMMUNOLOGY (2013)
Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells
Jagdeep K. Singh et al.
BREAST CANCER RESEARCH (2013)
Identifying factors that impact survival among women with inflammatory breast cancer
S. Dawood et al.
ANNALS OF ONCOLOGY (2012)
CXCL10 Promotes Osteolytic Bone Metastasis by Enhancing Cancer Outgrowth and Osteoclastogenesis
Jong-Ho Lee et al.
CANCER RESEARCH (2012)
Evaluation of CXCL10 as a novel serum marker for predicting liver metastasis and prognosis in colorectal cancer
Yuji Toiyama et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Preoperative serum value of sialyl Lewis X predicts pathological nodal extension and survival in patients with surgically treated small cell lung cancer
Takashi Iwata et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
What hypotheses do nonparametric two-group tests actually test?
Ronan M. Conroy
STATA JOURNAL (2012)
Sialyl Lewisx-dependent binding of human monocyte-derived dendritic cells to selectins
Zelia Silva et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Cytokine disbalance in common human cancers
Zoran Culig
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Selectin Ligand Sialyl-Lewis x Antigen Drives Metastasis of Hormone-Dependent Breast Cancers
Sylvain Julien et al.
CANCER RESEARCH (2011)
Serum Chemokine CXC Ligand 10 (CXCL10) Predicts Fibrosis Progression After Liver Transplantation for Hepatitis C Infection
Marie-Luise Berres et al.
HEPATOLOGY (2011)
CSLEX (Sialyl Lewis X) is a Useful Tumor Marker for Monitoring of Breast Cancer Patients
Tomoyuki Fujita et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2011)
The emerging role of CXCL10 in cancer (Review)
Mingli Liu et al.
ONCOLOGY LETTERS (2011)
Proinflammatory Cytokines in Breast Cancer: Mechanisms of Action and Potential Targets for Therapeutics
Jodi E. Goldberg et al.
CURRENT DRUG TARGETS (2010)
Selectins promote tumor metastasis
Heinz Laeubli et al.
SEMINARS IN CANCER BIOLOGY (2010)
Selectins as Mediators of Lung Metastasis
Heinz Laubli et al.
CANCER MICROENVIRONMENT (2010)
Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia
Alessandra Ferrajoli et al.
BLOOD (2008)
The inflammatory chemokines CCL2 and CCL5 in breast cancer
Gali Soria et al.
CANCER LETTERS (2008)
Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: A basis for tumor-promoting interactions
Gali Soria et al.
CYTOKINE (2008)
Is sialyl Lewis x antigen expression a prognostic factor in patients with breast cancer?
Prisca Sozzani et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2008)
Targeting selectins and selectin ligands in inflammation and cancer
Steven R. Barthel et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
Oestrogen receptor negative breast cancers exhibit high cytokine content
Carine Chavey et al.
BREAST CANCER RESEARCH (2007)
Significance of interleukin-6 (IL-6) in breast cancer (review)
Heike Knuepfer et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Cytokines in breast cancer
A. Nicolini et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2006)
Combined measurement of serum sialyl Lewis X with serum CA15-3 in breast cancer patients
J Kurebayashi et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2006)
Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis
R Kannagi et al.
CANCER SCIENCE (2004)
Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival
IH Benoy et al.
CLINICAL CANCER RESEARCH (2004)
Circulating interleukin-6 predicts survival in patients with metastatic breast cancer
R Salgado et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Relationship of sialyl-Lewisx/a underexpression and E-cadherin overexpression in the lymphovascular embolus of inflammatory breast carcinoma
ML Alpaugh et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Expression of ABH/Lewis-related antigens as prognostic factors in patients with breast cancer
T Nakagoe et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2002)
Share Paper
